Berkeley, CA, United States of America

John G Flannery

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 325(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Innovations of John G Flannery

Introduction

John G Flannery is a prominent inventor based in Berkeley, CA, known for his significant contributions to the field of ocular disease treatment. With a total of 17 patents to his name, Flannery has made remarkable advancements in gene therapy, particularly through the use of adeno-associated virus (AAV) technology.

Latest Patents

Flannery's latest patents include groundbreaking work on compositions and methods for treating ocular diseases. One notable patent describes recombinant adeno-associated virus (AAV) virions with altered capsid proteins, which enhance the ability to cross barriers between intravitreal fluid and retinal cells. This innovation results in greater infectivity of retinal cells compared to wild-type AAV. Additionally, he has developed methods for delivering gene products to retinal cells, further advancing the potential for effective treatments in ocular health. Another significant patent focuses on AAV virions with variant capsids, which also facilitate the delivery of gene products to retinal cells, showcasing his commitment to improving therapeutic options for individuals with retinal conditions.

Career Highlights

Flannery has had a distinguished career, working at esteemed institutions such as the University of California and the University of Pennsylvania. His research has not only contributed to the scientific community but has also paved the way for innovative treatments that could change the lives of many patients suffering from ocular diseases.

Collaborations

Throughout his career, Flannery has collaborated with notable colleagues, including David V Schaffer and Meike Visel. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

John G Flannery's work exemplifies the spirit of innovation in the field of ocular disease treatment. His contributions through patents and collaborations highlight the importance of research in developing effective therapies. His ongoing efforts continue to inspire advancements in gene therapy and ocular health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…